Meeting
2016 Gastrointestinal Cancers Symposium
Survival impact of neoadjuvant therapy in resected pancreatic cancer.
Authors
Katelin Anne Mirkin
Penn State Milton S. Hershey Medical Center, Hershey, PA
Katelin Anne Mirkin , Christopher S Hollenbeak , Joyce Wong
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 367)
DOI
10.1200/jco.2016.34.4_suppl.367
Abstract #
367
Poster Bd #
J3
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Survival outcomes between surgery with adjuvant therapy compared to neoadjuvant therapy with surgery in stage I pancreatic adenocarcinoma: Results from a large national cancer database.
First Author: Samit Kumar Datta
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A prospective translational study investigating the association of gut microbiome (GM) diversity with pathological complete response (pCR) after neoadjuvant treatment in early stage rectal and esophageal cancers.
First Author: Ronan Andrew Mc Laughlin
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Multiagent neoadjuvant chemotherapy compared to upfront surgery in pancreatic cancer of the body and tail using the National Cancer Database.
First Author: Oskar Franklin
Poster
2018 ASCO Annual Meeting
Adjuvant treatment for resected sub-centimeter T1 pancreatic cancer.
First Author: Walid Labib Shaib